(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Figure 1
A possible diagnostic work-up in palpable thyroid nodules.1Control visit after 4 weeks (clinical examination plus ultrasound; FNAB – if indicated by, for example, palpable solid remnants
of the cyst or peripherally localized solid tissue within the cystic lesion). 2Next visit after 6–8 weeks and then a 3 month interval (supplementary l-T4 therapy if indicated; surgery if relapse). 3Higher risk of malignancy in nonclassic subtype. 4Consider molecular markers: if positive–surgery, if negative–surgery in cold and hot nodules vs follow-up in a warm nodule.
5Next visit after 4–6 weeks and then a 3 month interval (l-T4 – if indicated and consider FNAB or direct surgery if tumor enlargement or suspicious appearance on US). 6Any palpable solid/or mixed, cold/or hot nodule should be removed even with benign cytology but the time and the extent of
surgery may differ, depending on all the diagnostic data.
AlessandriAJ, Goddard KJ, Blair GK, Fryer CJH & Schultz KR 2000 Age is the major determinant of recurrence in pediatric differentiated thyroid carcinoma. Medical and Pediatric Oncology3541–46.
Al-ShaikhA, Ngan B, Daneman A & Daneman D 2001 Fine-needle aspiration biopsy in the management of thyroid nodules in children and adolescents. Journal of Pediatrics138140–142.
AmrikachiM, Ponder TB, Wheeler TM, Smith D & Ramzy I 2005 Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates. Diagnostic Cytopathology32189–192.
ApelRL, Ezzat S, Bapat BV, Pan N, LiVolsi VA & Asa SL 1995 Clonality of thyroid nodules in sporadic goiter. Diagnostic and Molecular Pathology4113–121.
ArditoG, Pintus C, Revelli L, Grottesi A, Modugno R, Vincenzoni C, Fadda G & Perrelli L 2001 Thyroid tumors in children and adolescents: preoperative study. European Journal of Pediatric Surgery11154–157.
AriciC, Erdogan O, Altunbas H, Boz A, Melikoglu M, Karayalcin B & Karpuzoglu T 2002 Differentiated thyroid carcinoma in children and adolescents: clinical characteristics, treatment and outcome of 15 patients.
Hormone Research57153–156.
AttieJA1996 Carcinoma of the thyroid in children and adolescents. In Pediatric Endocrinology, edn 3, pp 423–432. Ed F Lifshitz F. New York: Marcel Dekker.
AvruchJ, Khokhlatchev A, Kyriakis JM, Luo Z, Tzivion G, Vavvas D & Zhang XF 2001 Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade. Recent Progress in Hormone Research56127–155.
BartolazziA, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F et al.2001 Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet3571644–1650.
BelfioreA, Giuffrida D, La Rosa GL, Ippolito O, Russo G, Fiumara A, Vigneri R & Filetti S 1989 High frequency of thyroid cancer in cold thyroid nodules occurring at young age. Acta Endocrinologica121197–202.
BennedbaeckFN & Hegedus L 2000 Management of the solitary thyroid nodule: results of a North American survey. Journal of Clinical Endocrinology and Metabolism852493–2498.
BennedbaeckFN, Perrild H & Hegedus L 1999 Diagnosis and treatment of the solitary thyroid nodule. Results of a European survey. Clinical Endocrinology50357–363.
BernetVJ, Anderson J, Vaishnav Y, Solomon B, Adair CF, Saji M, Burman KD, Burch HB & Ringel MD 2002 Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse
transcription-polymerase chain reaction. Journal of Clinical Endocrinology and Metabolism874792–4796.
BevanS, Pal T, Greenberg CR, Green H, Wixey J, Bignell G, Narod SA, Foulkes WD, Stratton MR & Houlston RS 2001 A comprehensive analysis of MNG1, TCO1, fPTC, PTEN, TSHR and TRKA in familial nonmedullary thyroid cancer: confirmation of
linkage to TCO1. Journal of Clinical Endocrinology and Metabolism863701–3704.
BlackburnDJ, Michel LA, Rosiere A, Trigaux J-P & Donckier JE 2001 Occurrence of thyroid papillary carcinoma in young patients. A Chernobyl connection? Journal of Pediatric Endocrinology and Metabolism14503–506.
BockhornM, Frilling A, Rewerk S, Liedke M, Dirsch O, Schmid KW & Broelsch CE 2004 Lack of elevated serum carcinoembryonic antigen and calcitonin in medullary thyroid carcinoma. Thyroid14468–470.
BonnemaSJ, Bennedbaeck FN, Wiersinga WM & Hegedus L 2000 Management of the nontoxic multinodular goitre: a European questionnaire survey. Clinical Endocrinology535–12.
BonnemaSJ, Bennedbaeck FN, Ladenson PW & Hegedus L 2002 Management of the nontoxic multinodular goiter: a North American survey. Journal of Clinical Endocrinology and Metabolism87112–117.
BrandiML, Gagel RF, Angeli A, Bilezikan JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A et al.2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism865658–5671
BugalhoMJM, Santos JR & Sobrinho L 2005 Preoperative diagnosis of medullary thyroid carcinoma: fine needle aspiration cytology as compared with serum calcitonin
measurement. Journal of Surgical Oncology9156–60.
CanzianF, Amati P, Harach R, Kraimps J-L, Lesueur F, Barbier J, Levillain P, Romeo G & Bonneau D 1998 A gene predisposing to familial thyroid tumors with cell oxyphilia maps to chromosome 19p13.2. American Journal of Human Genetics631743–1748.
ChhiengDC, Ross JS & McKenna BJ 1997 CD44 immunostaining of thyroid fine-needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear
grooves and inclusions. Cancer81157–162.
ChiesaF, Tradati N, Calabrese L, Gibelli B, Giugliano G, Paganelli G, De Cicco C, Grana C, Tosi G, DeFiori E et al.2004 Thyroid disease in northern Italian children born around the time of the Chernobyl nuclear accident. Annals of Oncology151842–1846.
CiampiR, Knauf JA, Kerler R, Gandhi M, Zhu Zhaowen, Nikiforova MN, Rabes HM, Fagin JA & Nikiforov YE 2005 Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer. Journal of Clinical Investigation11594–101.
CohenA, Rovelli A, van Lint MT, Merlo F, Gaiero A, Mulas R, Balduzzi A, Corti P, Uderzo C & Bacigalupo A 2001 Secondary thyroid carcinoma after allogenic bone marrow transplantation during childhood. Bone Marrow Transplantation281125–1128.
CohenY, Xing M, Mambo E, Guo Z, Wu G, Trink B, Beller U, Westra WH, Ladenson PW & Sidransky D 2003 BRAF mutation in papillary thyroid carcinoma. Journal of the National Cancer Institute95625–627.
CooperDS, Axelrod L, De Groot LJ, Vickery AL Jr & Maloof F 1981 Congenital goiter and the development of metastatic follicular carcinoma with evidence for a leak of nonhormonal iodide:
clinical, pathological, kinetic, and biochemical studies and a review of the literature. Journal of Clinical Endocrinology and Metabolism52294–306.
CorriasA, Einaudi S, Chiorboli E, Weber G, Crino A, Andreo M, Cesaretti G, De Sanctis L, Messina MF, Segni M et al.2001 Accuracy of fine-needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional
clinical, laboratory, and imaging approaches. Journal of Clinical Endocrinology and Metabolism864644–4648.
CotterillSJ, Perace MS & Parker L 2001 Thyroid cancer in children and young adults in the North of England. Is increasing incidence related to the Chernobyl accident?
European Journal of Cancer371020–1026.
CvejicD, Savin S, Paunovic I, Tatic S, Havelka M & Sinadinovic J 1998 Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Research182637–2641.
DaviesH, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W et al.2002 Mutations of the BRAF gene in human cancer. Nature417949–954.
DeftosLJ2004 Should serum calcitonin be routinely measured in patients with thyroid nodules – will the law answer before endocrinologists
do? Journal of Clinical Endocrinology and Metabolism894768–4769.
DegnanBM, McClellan DR & Francis GL 1996 An analysis of fine-needle aspiration biopsy of the thyroid in children and adolescents. Journal of Pediatric Surgery31903–907.
DemidchikE, Kazakov VS, Astakhova LN, Okeanov AE & Demidchik YE 1994 Thyroid cancer in children after the Chernobyl accident: clinical and epidemiological evaluation of 251 cases in the Republic
of Belarus. In Nagasaki Symposium, Chernobyl Update and Future, pp 21–30. Ed. S Nagataki. Amsterdam: Excerpta Medica, Elsevier Press.
DerwahlM & Studer H 2000 Multinodular goitre: ‘much more to it than simply iodine deficiency’. Bailliere’s Clinical Endocrinology and Metabolism14577–600.
DerwahlM, Broecker M & Kraiem Z 1999 Clinical Review 101: Thyrotropin may not be the dominant growth factor in benign and malignant thyroid tumors. Journal of Clinical Endocrinology and Metabolism84829–834.
DobynsBM, Sheline GE, Workman JB, Tompkins EA, McConahey WM & Becker DV 1974 Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis
therapy follow-up study. Journal of Clinical Endocrinology and Metabolism38976–998.
DominguesR, Mendonca E, Sobrinho L & Bugalho MJ 2005 Searching for RET/PTC rearrangements and BRAF V599E mutation in thyroid aspirates might contribute to establish a preoperative
diagnosis of papillary thyroid carcinoma. Cytopathology1627–31.
DrozdV, Polyanskaya O, Ostapenko V, Biko I & Reiners C 2002 Systematic ultrasound screening as a significant tool for early detection of thyroid carcinoma in Belarus. Journal of Pediatric Endocrinology and Metabolism15979–984.
EliseiR, Bottici V, Luchetti F, Di Coscio G, Romei C, Grasso L, Miccoli P, Iacconi P, Basolo F, Pinchera A et al.2004 Impact of routine measurement of serum calcitonin on the diagnosis and outcome of medullary thyroid cancer: experience in
10,864 patients with nodular thyroid disorders. Journal of Clinical Endocrinology and Metabolism89163–168.
EngC, Clayton D, Schuffenecker I, Lenoir G, Cote G, Gagel RF, van Amstel HK, Lips CJ, Nishisho I, Takai SI et al.1996 The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type
2: International RET Mutation Consortium analysis. Journal of the American Medical Association2761575–1579.
FaginJA2004a Challenging dogma in thyroid cancer molecular genetics – role of RET/PTC and BRAF in tumor initiation. Journal of Clinical Endocrinology and Metabolism894264–4266.
FaginJA2004b How thyroid tumors start and why it matters: kinase mutants as targets for solid cancer pharmacotherapy. Journal of Endocrinology183249–256.
FavusMJ, Schneider AB, Stachura ME, Arnold JE, Ryo UY, Pinsky SM, Colman M, Arnold MJ & Frohman LA 1976 Thyroid cancer as a late consequence of head-neck irradiation: evaluation of 1056 patients. New England Journal of Medicine2941019–1025.
FinleyDJ, Arora N, Zhu B, Gallagher L & Fahey III TJ 2004 Molecular profiling distinguishes papillary carcinoma from benign thyroid nodules. Journal of Clinical Endocrinology and Metabolism893214–3223.
FranceschiS1998 Iodine intake and thyroid carcinoma – a potential risk factor. Experimental and Clinical Endocrinology and Diabetes106 (Suppl 3) S38–S44.
FuscoA, Viglietto G & Santoro M 2005 A new mechanism of BRAF activation in human thyroid papillary carcinomas. Journal of Clinical Investigation11520–23.
GandolfiPP, Frisina A, Raffa M, Renda F, Rocchetti O, Ruggeri C & Tombolini A 2004 The incidence of thyroid carcinoma in multinodular goiter: retrospective analysis. Acta Biomedica de l’Ateneo Parmense75114–117.
GarciaCJ, Daneman A, Thorner P & Daneman D 1992 Sonography of multinodular thyroid gland in children and adolescents. American Journal of Diseases of Children146811–816.
GasbarriA, Martegani MP, Del Prete F, Lucante T, Natali PG & Bartolazzi A 1999 Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. Journal of Clinical Oncology173494–3502.
GiardielloF, Offerhaus G, Lee D, Krush A, Tersmette A, Booker S, Kelley NC & Hamilton SR 1993 Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut341394–1396.
GimmO, Sutter T & Dralle H 2001 Diagnosis and therapy of sporadic and familial medullary thyroid carcinoma. Journal of Cancer Research and Clinical Oncology127156–165.
GiordanoGG, Tagliabue E & Pupa SM 2004 New basic discoveries and frontiers in diagnosis, prognosis and prediction of response to therapy in human thyroid, urinary
bladder, and prostate tumors. Journal of Cellular Physiology198343–349.
GiordanoTJ, Kuick R, Thomas DG, Misek DE, Vinco M, Sanders D, Zhu Z, Ciampi R, Roh M, Shedden K et al.2005 Molecular classification of papillary thyroid carcinoma: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression
profiles discovered by DNA microarray analysis. Oncogene66646–6656.
GouldE, Watzak L, Chamizo W & Albores-Saavedra J 1989 Nuclear grooves in cytologic preparations. A study of the utility of this feature in the diagnosis of papillary thyroid carcinoma.
Acta Cytologica3316–20.
Gregory PowellJ, Wang X, Allard BL, Sahin M, Wang XL, Hay ID, Hiddinga HJ, Deshpande SS, Kroll TG, Grebe SK et al.2004 The PAX8/PPARgamma fusion oncoprotein transforms immortalized human thyrocytes through a mechanism probably involving wild-type
PPARgamma inhibition. Oncogene233634–3641.
GriecoM, Santoro M, Berlingieri MT, Melillo RM, Donghi R, Bongarzone I, Pierotti MA, Della Porta G, Fusco A & Vecchio G 1990 PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.
Cell60557–563.
HamburgerJI1994 Diagnosis of thyroid nodules by fine needle aspiration biopsy: use and abuse. Journal of Clinical Endocrinology and Metabolism79335–339.
HarachHR & Williams ED 1995 Thyroid cancer and thyroiditis in the goitrous region of Salta, Argentina, before and after iodine prophylaxis. Clinical Endocrinology43701–706.
HarachHR, Escalante DA, Onativia A, Lederer Outes J, Saravia Day E & Williams ED 1985 Thyroid carcinoma and thyroiditis in an endemic goitre region before and after iodine prophylaxis. Acta Endocrinologica (Copenhagen)10855–60.
HaugenBR, Woodmansee WW & McDermott MT 2002 Toward improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours. Clinical Endocrinology56281–290.
HempelmannJH1968 Risk of thyroid neoplasms after irradiation in childhood: studies of population exposed to radiation in childhood show a
dose-response over a wide dose range. Science160159–163.
HirokawaM, Carney JA, Goellner JR, DeLellis RA, Heffess CS, Katoh R, Tsujimoto M & Kakudo K 2002 Observer variation of encapsulated follicular lesions of the thyroid gland. American Journal of Surgical Pathology261508–1514.
HodakSP & Burman KD 2004 The calcitonin conundrum – is it time for routine measurement of serum calcitonin in patients with thyroid nodules? Journal of Clinical Endocrinology and Metabolism89511–514.
HolmesJM, Engel JM, Ticho BH, Mets MB & Del Monte MA 1995 Syndromes with ophthalmic manifestations. In Pediatric Ophthalmology and Strabismus, edn 1, pp 707–721. Ed. KW Wright. St Louis: Mosby.
HuS, Ewertz M, Tufano RP, Brait M, Lopes Carvalho A, Liu D, Tufaro AP, Basaria S, Cooper DS, Sidransky D et al.2006 Detection of serum DNA methylation markers: a novel diagnostic tool for thyroid cancer. Journal of Clinical Endocrinology and Metabolism9198–104.
HuangSM, Chen HD, Wen TY & Kun MS 2002 Right thyroid hemiagenesis associated with papillary thyroid cancer and an ectopic prelaryngeal thyroid: a case report. Journal of the Formosan Medical Association101368–371.
ItoT, Seyam T, Tsuyama N, Hayashi T, Hayashi Y, Dohi K, Nakamura N & Akiyama N 1992 Unique association of p53 mutations with undifferentiated but not with differentiated carcinomas of the thyroid gland. Cancer Research521369–1371.
JarzabB, Handkiewicz-Junak D & Wloch J 2005 Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocrine-Related Cancer12773–803.
JonckheerMH, Velkeniers B, Van Haelst L & Van Blerk M 1992 Further characterization of iodide-induced hyperthyroidism based on the direct measurement of intrathyroidal iodine stores.
Nuclear Medicine Communications13114–118.
KhuranaKK, Labrador E, Izquierdo R, Mesonero CE & Pisharodi LR 1999 The role of fine-needle aspiration biopsy in the management of thyroid nodules in children, adolescents, and young adults:
a multi-institutional study. Thyroid9383–386.
KhuranaKK, Truong LD, LiVolsi VA & Baloch ZW 2003 Cytokeratin 19 immunolocalization in cell block preparation of thyroid aspirates. An adjunct to fine-needle aspiration diagnosis
of papillary thyroid carcinoma. Archives of Pathology and Laboratory Medicine127579–583.
KimKH, Suh KS, Kang DW & Kang DY 2005 Mutations of the BRAF gene in papillary thyroid carcinoma and Hashimoto’s thyroiditis. Pathology International55540–545.
KimuraET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE & Fagin JA 2003 High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF
signaling pathway in papillary thyroid carcinoma. Cancer Research11454–1457.
KiniSR1996 Papillary carcinoma. In Guides to Clinical Aspiration Biopsy: Thyroid, edn 2, pp 129–223. Ed. SR Kini. New York, Tokyo: Igaku-Shoin Medical Publisher.
KirklandRT, Kirkland JL, Rosenberg HS, Harberg FJ, Librik L & Clayton GW 1973 Solitary thyroid nodules in 30 children and report of a child with a thyroid abscess. Pediatrics5185–90.
KochCA & Sarlis NJ 2001 The spectrum of thyroid diseases in childhood and its evolution during transition to adulthood: Natural history, diagnosis,
differential diagnosis and management. Journal of Endocrinological Investigation24659–675.
KormanE & Niedziela M 2001 Diagnostyka i leczenie choroby guzkowej tarczycy u dzieci i mlodziezy (Diagnosis and treatment of thyroid nodular disease
in children and adolescents). Standardy Medyczne126–32.
KormanE, Niedziela M, Rybakowa M, Dziatkowiak H, Dorant B, Kalicka-Kasperczyk A, Malecka-Tendera E, Nizankowska-Blaz T, Romer TE,
Szewczyk L et al.1999 Thyroid nodular disease in children – a preliminary Polish multicenter study. Hormone Research51 (Suppl. 2) 18.
KotaniT, Umeki K, Yamamoto I, Maesaka H, Tachibana K & Ohtaki S 1999 A novel mutation in the human thyroid peroxidase gene resulting in a total iodide organification defect. Journal of Endocrinology160267–273.
KovacsRB, Foldes J, Winkler G, Bodo M & Sapi Z 2003 The investigation of galectin-3 in diseases of the thyroid gland. European Journal of Endocrinology149449–453.
KumagaiA, Namba H, Saenko V, Ashizawa K, Ohsturu A, Ito M, Ishikawa N, Sugino K, Ito K, Jeremiah S et al.2004 Comment: low frequency of BRAFT1796A mutations in childhood carcinomas. Journal of Clinical Endocrinology and Metabolism894280–4284.
LaffertyAR & Batch JA 1997 Thyroid nodules in childhood and adolescence – thirty years of experience. Journal of Pediatric Endocrinology and Metabolism10479–486.
LeenhardtL, Hejblum G, Franc B, Du Pasquier Fediaevsky L, Delbot T, Le Guillouzic D, Menegaux F, Guillausseau C, Hoang C, Turpin G et al.1999 Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules. Journal of Clinical Endocrinology and Metabolism8424–28.
LiawD, Marsh DJ, Li J, Dahia PLM, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M et al.1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics1664–67.
LimaJ, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A et al.2004BRAF mutations are not a major event in post-Chernobyl childhood thyroid carcinomas. Journal of Clinical Endocrinology and Metabolism894267–4271.
LimaJ, Trovisco V, Soares P, Máximo V, Magalhães J, Salvatore G, Santoro M, Bogdanova T, Tronko M, Abrosimov A et al.2005 Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas.
Cancer Letters230149–150.
LippiF, Ferrari C, Manetti L, Rago T, Santini F, Monzani F, Bellitti P, Papini E, Busnardo B, Angelini F et al.1996 Treatment of solitary autonomous thyroid nodules by percutaneous ethanol injection: results of an Italian multicenter study.
The Multicenter Study Group. Journal of Clinical Endocrinology and Metabolism813261–3264.
LohK-C, Greenspan FS, Dong F, Miller TR & Yeo PPB 1999 Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism84458–463.
Lugo-VicenteH, Ortiz VN, Irizarry H, Camps JI & Pagan V 1998 Pediatric thyroid nodules: management in the era of fine-needle aspiration. Journal of Pediatric Surgery33302–305.
LyshchikA, Drozd V, Demidchik Y & Reiners C 2005 Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US. Radiology235604–613.
MarshDJ, Mulligan LM & Eng C 1997 RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma. Hormone Research47168–178.
McGirrEM, Clement WE, Currie AR & Kennedy JS 1959 Impaired dehalogenase activity as a cause of goiter with malignant changes. Scottish Medical Journal4232–240.
McHenryCR, Danish R, Murphy T & Marty JJ 1993 Atypical thyroglossal duct cyst: a rare cause for a solitary cold thyroid nodule in childhood. Surgery59223–228.
Medeiros-NetoG, Gilda-Costa MJ, Santos CLS, Medina AM, Costa e Silva J, Tsou RM & Sobrinho-Simoes M 1998 Metastatic thyroid carcinoma arising from congenital goiter due to mutation in the thyroperoxidase gene. Journal of Clinical Endocrinology and Metabolism834162–4166.
MellerJ & Becker W 2002 The continuing importance of thyroid scintigraphy in the era of high-resolution ultrasound. European Journal of Nuclear Medicine and Molecular Imaging29S425–S438.
NambaH, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, Ohtsuru A, Saenko VA, Kanematsu T & Yamashita S 2003 Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. Journal of Clinical Endocrinology and Metabolism884393–4397.
NascimentoAC, Guedes DR, Santos CS, Knobel M, Rubio IG & Medeiros-Neto G 2003 Thyroperoxidase gene mutations in congenital goitrous hypothyroidism with total and partial iodide organification defect.
Thyroid131145–1151.
NiedzielaM2002 Choroba guzkowa tarczycy u dzieci i mlodziezy w regionie wielkopolskim – analiza klinicznych i genetycznych czynnikow wystepowania
nowotworu (Thyroid nodular disease of children and adolescents in the Wielkopolska region – an analysis of clinical and genetic
factors in the occurrence of neoplasia). Rozprawa habilitacyjna (Habilitation thesis) Akademia Medyczna im. Karola Marcinkowskiego w Poznaniu. Poznan: Poznan University of Medical Sciences.
NiedzielaM & Korman E 2003 Risk of neoplasm in autoimmune thyroid disease in children – transition from iodine deficiency to iodine sufficiency. 42nd
Annual Meeting ESPE: Miniposters, 15 (MP2–5/P1–380) Ljubljana (Slovenia), 18–21 September 2003.
NiedzielaM, Ambrugger P, Biebermann H, Krude H, Schnabel D, Korman E & Grueters-Kieslich A 2001 TPO gene as a candidate gene in the pathogenesis of thyroid neoplasia of patients with congenital hypothyroidism. Journal of Endocrinological Investigation24 (Suppl to No. 6) 43.
NiedzielaM, Breborowicz D, Trejster E & Korman E 2002a Hot nodules in children and adolescents in western Poland from 1996 to 2000: clinical analysis of 31 patients. Journal of Pediatric Endocrinology and Metabolism15823–830.
NiedzielaM, Maceluch J & Korman E 2002b Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. Journal of Clinical Endocrinology and Metabolism874411–4415.
NiedzielaM, Korman E, Breborowicz D, Trejster E, Harasymczuk J, Warzywoda M, Rolski M & Breborowicz J 2004 A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence
of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster. Pediatric Blood and Cancer4284–93.
NikiforovY, Gnepp DR & Fagin JA 1996 Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis.
Journal of Clinical Endocrinology and Metabolism819–14.
NikiforovYE, Rowland JM, Bove KE, Monforte-Munoz H & Fagin JA 1997 Distinct pattern of ret oncogene rearrangements in morphological variants of radiation-induced and sporadic thyroid papillary
carcinomas in children. Cancer Research571690–1694.
NikiforovaMN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A et al.2003a BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas
arising from papillary carcinomas. Journal of Clinical Endocrinology and Metabolism885399–5404.
NikiforovaMN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW 2nd, Tallini G, Kroll TG & Nikiforov YE 2003b Point mutations and PAX8-PPARgamma rearrangements in thyroid tumors: evidence for distinct molecular pathway in thyroid follicular
carcinoma. Journal of Clinical Endocrinology and Metabolism882318–2326.
NikiforovaMN, Ciampi R, Salvatore G, Santoro M, Gandhi M, Knauf JA, Thomas GA, Jeremiah S, Bogdanova TI, Tronko MD et al.2004 Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas. Cancer Letters2091–6.
PaciniF, Mariotti S, Formica N, Elisei R, Anelli S, Capotorti E & Pinchera A 1988 Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome. Acta Endocrinologica (Copenhagen)119373–380.
PaciniF, Vorontsova T, Demidchik EP, Molinaro E, Agate L, Romel C, Shavrova E, Cherstvoy ED, Ivashkevitch Y, Kuchinskaya E et al.1997 Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma
in Italy and France. Journal of Clinical Endocrinology and Metabolism823563–3569.
PapiniE, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V & Pacella CM 2002 Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. Journal of Clinical Endocrinology and Metabolism871941–1946.
PapottiM, Volant M, Saggiorato E, Deandreis D, Veltri A & Orlandi F 2002 Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. European Journal of Endocrinology147515–521.
PapottiM, Rodriguez J, De Pompa R, Bartolazzi A & Rosai J 2004 Galectin-3 and HBME-1 expression in well-differentiated thyroid tumors with follicular architecture of uncertain malignant
potential. Modern Pathology18541–546.
ParacchiA, Ferrari C, Livraghi T, Reschini E, Macchi RM, Bergonzi M & Raineri P 1992 Percutaneous intranodular ethanol injection: a new treatment for autonomous thyroid adenoma. Journal of Endocrinological Investigation15353–362.
PellegritiG, Belfiore A, Giuffrida D, Lupo L & Vigneri R 1998 Outcome of differentiated thyroid cancer in Graves’ patients. Journal of Clinical Endocrinology and Metabolism832805–2809.
PenkoK, Livezey J, Fenton C, Patel A, Nicholson D, Flora M, Oakley K, Tuttle RM & Francis G 2005 BRAF mutations are uncommon in papillary thyroid cancer of young patients. Thyroid15320–325.
PizziniAM, Papi G, Corrado S, Carani C & Roti E 2005 Thyroid hemiagenesis and incidentally discovered papillary thyroid cancer: case report and review of the literature. Journal of Endocrinological Investigation2866–71.
Polish Guidelines 2001 [Diagnosis and treatment of malignant thyroid neoplasms. Recommendations of the Scientific Committee of the 2nd Scientific
Conference ‘Thyroid Carcinoma 2000’]. Wiadomosci Lekarskie45 (Suppl 1) 443–461.
PowellN, Jeremiah S, Morishita M, Dudley E, Bethel J, Bogdanova T, Tronko M & Thomas G 2005 Frequency of BRAF T1796A mutation in papillary thyroid carcinoma relates to age of patient at diagnosis and not to radiation
exposure. Journal of Pathology205558–564.
RaabSS, Silvermann JF, Elsheikh TM, Thomas PA & Wakely PE 1995 Pediatric thyroid nodules: disease demographics and clinical management as determined by fine needle aspiration biopsy. Pediatrics9546–49.
Rabska-PietrzakB, Niedziela M & Korman E 1998 Ropne zapalenie tarczycy u 11-letniej dziewczynki (Suppurative thyroiditis in a 11-year-old girl). Pediatria Praktyczna65–11.
RaueF, Kotzerke J, Reinwein D, Schroder S, Roher HD, Deckart H, Hofer R, Ritter M, Seif F & Buhr H 1993 Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma
Register. Clinical Investigation717–12.
Reed LarsenP, Davies TF & Hay ID 1998 The thyroid gland. In Williams Textbook of Endocrinology, edn 9, pp 389–515. Eds JD Wilson, DW Foster, HM Kronenberg & P Reed Larsen. Philadelphia: WB Saunders Company.
RefetoffS, Harrison J, Karanfilski BT, Kaplan EL, De Groot LJ & Bekerman C 1975 Continuing occurrence of thyroid carcinoma after irradiation to the neck in infancy and childhood. New England Journal of Medicine269171–175.
RivkeesSA, Sklar C & Freemark M 1998 Clinical review 99: The management of Graves’ disease in children, with special emphasis on radioiodine treatment. Journal of Clinical Endocrinology and Metabolism833767–3776.
RosaiJ, Carcangiu ML & De Lellis RA 1992 Tumors of the Thyroid Gland. In Atlas of Tumor Pathology, third series, pp 49–62. Eds J Rosai & LH Sobin. Washington DC: Armed Force Institute of Pathology.
RosenJ, He M, Umbricht C, Alexander HR, Dackiw AP, Zeiger MA & Libutti SK 2005 A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. Surgery1381050–1056.
RosenbaumE, Hosler G, Zahurak M, Cohen Y, Sidransky D & Westra WH 2005 Mutational activation of BRAF is not a major event in sporadic childhood papillary thyroid carcinoma. Modern Pathology18898–902.
RovelliA, Cohen A, Uderzo C, Dodero P, Brisigotti M, Castellani MR & Romano C 1997 Follicular cell carcinoma of the thyroid in a child after bone marrow transplantation for acute lymphoblastic leukemia. Acta Haematologica97225–227.
RussoD, Arturi F, Pontecorvi A & Filetti S 1999 Genetic analysis in fine-needle aspiration of the thyroid: a new tool for the clinic. Trends in Endocrinology and Metabolism10280–285
SabelMS, Staren ED, Gianakakis LM, Dwarakanathan S & Prinz RA 1997 Effectiveness of the thyroid scan in evaluation of the solitary thyroid nodule. American Surgeon63660–663.
SackMJ, Astengo-Osuna C, Lin BT, Battifora H & LiVolsi VA 1997 HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Modern Pathology10668–674.
SaggioratoE, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, Angeli A & Orlandi F 2001 Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism865152–5158.
SaggioratoE, De Pompa R, Volante M, Cappia S, Arecco F, Dei Tos AP, Orlandi F & Papotti M 2005 Characterization of thyroid ‘follicular neoplasm’ in fine-needle aspiration cytological specimens using a panel of immunohistochemical
markers: a proposal for clinical application. Endocrine-Related Cancer12305–317.
SamaanNA, Schultz PN, Hickey RC, Goepfert H, Haynie TP, Johnston DA & Ordonez NG 1992 The results of various modalities of treatment of well differentiated thyroid carcinomas: a retrospective review of 1599
patients. Journal of Clinical Endocrinology & Metabolism75714–720.
ShaffordEA, Kingston JE, Healy JC, Webb JA, Plowman PN & Reznek RH 1999 Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin’s disease. British Journal of Cancer80808–814.
SilvermanSH, Nussbaum M & Rausen AR 1979 Thyroid nodules in children: a ten year experience at one institution. Mount Sinai Journal of Medicine46460–463.
SingerPA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Bravermann LE, Clark OH, McDougall IR, Ain KV et al.1996 Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association.
Archives of Internal Medicine1562165–2172.
SklarC, Whitton J, Mertens A, Stovall M, Green D, Marina N, Greffe B, Wolden S & Robison L 2000 Abnormalities of the thyroid in survivors of Hodgkin’s disease: data from the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism853227–3232.
SoaresP, Trovisco V, Rocha AS, Lima J, Castro P, Preto A, Maximo V, Botelho T, Seruca R & Sobrinho-Simoes M 2003 BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC. Oncogene224578–4580.
SolbiattiL, Cioffi V & Ballarati E 1992 Ultrasonography of the neck. Radiologic Clinics of North America30941–954.
Stankowiak-KulpaH, Niedziela M, Ziemnicka K, Gryczynska M, Korman E & Sowinski J 2002 Children with differentiated thyroid carcinoma in the years 1999–2001. Pediatria Praktyczna10240.
StratakisCA, Courcoutsakis NA, Abati A, Filie A, Doppman JL, Carney JA & Shawker T 1997 Thyroid gland abnormalities in patients with the syndrome of spotty skin pigmentation, myxomas, endocrine overactivity, and
schwannomas (Carney complex). Journal of Clinical Endocrinology and Metabolism822037–2043.
StuderH & Derwahl M 1995 Mechanisms of nonneoplastic endocrine hyperplasia – a changing concept: a review focused on the thyroid gland. Endocrine Reviews16411–426.
TakanoT & Amino N 2002 Cancer-specific mRNAs in thyroid carcinomas: detection, use, and their implication in thyroid carcinogenesis. Endocrine Journal4997–107.
TakanoT, Miyauchi A, Matsuzuka F, Liu G, Higashiyama T, Yokozawa T, Kuma K & Amino N 1999 Preoperative diagnosis of medullary thyroid carcinoma by RT-PCR using RNA extracted from leftover cells within a needle used
for fine needle aspiration biopsy. Journal of Clinical Endocrinology and Metabolism84951–955.
TakanoT, Miyauchi A, Yoshida H, Kuma K & Amino N 2004 High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor
3 mRNA in thyroid follicular carcinomas. British Journal of Cancer901600–1605.
TanakaT, Umeki K, Yamamoto I, Sugiyama S, Noguchi S & Ohtaki S 1996 Immunohistochemical loss of thyroid peroxidase in papillary thyroid carcinoma: strong suppression of peroxidase gene expression.
Journal of Pathology17989–94.
TronkoMD, Bogdanova TI, Komissarenko IV, Epshtein OV, Oliynyk V, Kovalenko A, Likhtarev IA, Kairo I, Peters SB & LiVolsi VA 1999 Thyroid carcinoma in children and adolescents in Ukraine after the Chernobyl nuclear accident: statistical data and clinicomorphologic
characteristics. Cancer86149–156.
TronkoN, Bogdanova T, Kommisarenko I, Bolshova E, Oleinik V, Tereshchenko V, Epshtein Y & Chebotarev V 1996 Thyroid cancer in children and adolescents in Ukraine after the Chernobyl accident (1986–1995). In The Radiological Consequences of the Chernobyl Accident, pp 683–690. Eds A Karaoglou, G Desmet, GN Kelly & HG Menzel, ERU 16544 EN. Luxembourg: European Commission.
TrumpD, Farren B, Wooding C, Pang JT, Besser GM, Buchanan KD, Edwards CR, Heath DA, Jackson CE, Jansen S et al.1996 Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Quarterly Journal of Medicine89653–669.
Van VlietG, Glinoer D, Verelst J, Spehl M, Gompel C & Delange F 1987 Cold thyroid nodules in childhood: is surgery always necessary? European Journal of Pediatrics146378–382.
VarverakisE & Neonakis E 2002 Contribution of high-resolution ultrasonography in the differential diagnosis of benign from malignant thyroid nodules. Hormones151–56.
WasikowaR, Iwanicka Z, Zak T, Lukienczuk T & Sawicz-Birkowska K 1999 Nodular goiter and thyroid carcinoma in children and adolescents in a moderate endemic area (lower Silesia-Sudeten endemia)
in the last twelve years. Journal of Pediatric Endocrinology and Metabolism12645–652.
WeberKB, Shroyer KR, Heinz DE, Nawaz S, Said MS & Haugen BR 2004 The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. American Journal of Clinical Pathology122524–531.
WeissSD & Orlich CC 1991 Primary papillary carcinoma of a thyroglossal duct cyst: report of a case and literature review. British Journal of Surgery7887–89.
WilliamsED, The Chernobyl Pathologists Group 2000 Guest editorial: two proposals regarding the terminology of thyroid tumors. International Journal of Surgical Pathology8181–183.
XuX, Gandhi M, Nikiforova MN, Fischer AH & Nikiforov YE 2003 Molecular profile and clinical-pathologic features of the follicular variant of papillary thyroid carcinoma. An usually high
prevalence of ras mutations. Cancer Research12071–77.
YanoY, Uematsu N, Yashiro T, Hara H, Ueno E, Miwa M, Tsujimoto G, Aivoshi Y & Uchida K 2004 Gene expression profiling identifies platelet-derived growth factor as a diagnostic molecular marker for papillary thyroid
carcinoma. Clinical Cancer Research102035–2043.
YashiroT, Ito K, Akiba M, Kamaji Y, Obara T, Fujimoto Y, Hirayama A & Nakajima H. 1987 Papillary carcinoma of the thyroid arising from dyshormonogenetic goiter. Endocrinologia Japonica34955–964.